Bingbing Hao
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
-
- Epigenetics and DNA Methylation
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
- RNA modifications and cancer
- Histone Deacetylase Inhibitors Research
- Cancer-related gene regulation
Papers in
-
- Protein Degradation and Inhibitors 8
- Ubiquitin and proteasome pathways 7
- Epigenetics and DNA Methylation 4
- Histone Deacetylase Inhibitors Research 4
- DNA Repair Mechanisms 2
- Metabolism, Diabetes, and Cancer 2
- Oncology 5
- Peptidase Inhibition and Analysis 3
- Co-authors
- Minjia Tan (14 shared papers)Linhui Zhai (6 shared papers)Hong Yang (1 shared paper)Yafang Wang (1 shared paper)Min Huang (2 shared papers)Rongrui Wei (1 shared paper)Xiong Zhang (1 shared paper)Meiyu Geng (1 shared paper)
- Journals
- Acta Pharmacologica Sinica (4 papers)Cell (2 papers)Molecular Cell (2 papers)Genomics Proteomics & Bioinformatics (1 paper)Nucleic Acids Research (1 paper)
- Partner nations
- ChinaSouth KoreaSweden
In The Last Decade
Bingbing Hao
18 papers receiving 862 citations
Bingbing Hao's Hit Papers
Peers
Comparison fields: 5 of 77
- Cancer Research 187
- Molecular Biology 530
- Oncology 123
- Hematology 38
- Geriatrics and Gerontology 11
Countries citing papers authored by Bingbing Hao
This map shows the geographic impact of Bingbing Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingbing Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingbing Hao more than expected).
Fields of papers citing papers by Bingbing Hao
This network shows the impact of papers produced by Bingbing Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingbing Hao. The network helps show where Bingbing Hao may publish in the future.
Co-authors
The 25 scholars most cited alongside Bingbing Hao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Metabolic regulation of homologous recombination repair by MRE11 lactylation Hit paper breakdown → | 2023 | 360 |
| 2 | 2018 | 224 | |
| 3 | 2021 | 48 | |
| 4 | 2020 | 37 | |
| 5 | 2022 | 35 | |
| 6 | 2019 | 33 | |
| 7 | 2022 | 30 | |
| 8 | 2024 | 24 | |
| 9 | 2024 | 20 | |
| 10 | 2023 | 17 | |
| 11 | 2022 | 12 | |
| 12 | 2024 | 12 | |
| 13 | 2024 | 5 | |
| 14 | 2022 | 5 | |
| 15 | 2019 | 4 | |
| 16 | 2024 | 2 | |
| 17 | 2019 | 2 | |
| 18 | 2023 | 1 |
About Bingbing Hao
Bingbing Hao is a scholar working on Molecular Biology, Oncology, Geriatrics and Gerontology, Toxicology and Physiology, having authored 18 papers that have together received 871 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (8 papers), Ubiquitin and proteasome pathways (7 papers), Epigenetics and DNA Methylation (4 papers), Histone Deacetylase Inhibitors Research (4 papers), Peptidase Inhibition and Analysis (3 papers), Pancreatic function and diabetes (2 papers), DNA Repair Mechanisms (2 papers) and Metabolism, Diabetes, and Cancer (2 papers). The work is most often cited by research in Cancer Research (187 citations), Molecular Biology (530 citations), Oncology (123 citations), Hematology (38 citations) and Geriatrics and Gerontology (11 citations). Bingbing Hao has collaborated with scholars based in China, South Korea and Sweden. Frequent co-authors include Minjia Tan, Linhui Zhai, Hong Yang, Yafang Wang, Min Huang, Rongrui Wei, Xiong Zhang, Meiyu Geng, Yi Chen and Yi Su. Their work appears in journals such as Acta Pharmacologica Sinica, Cell, Molecular Cell, Genomics Proteomics & Bioinformatics and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.